As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy and efficiency.

Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

"Don't be afraid to go to the doctor and get checked. But if you are it's ok. Just make sure you do it afraid, but ultimately, get it done," she says.

One in 3 women will be affected by heart disease. One in 100 babies are born with a congenital heart defect. Meet 3 women and ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...